Autism Spectrum Disorders Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Autism Spectrum Disorders Market covers analysis By Type (Autistic Disorder, Pervasive Developmental Disorder, Asperger syndrome, Others); Treatment Type (Drug Therapy, Communication and Behavioral Therapy) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Mar 2024

  • Report Code : TIPRE00008010
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET INTRODUCTION

Autism Spectrum Disorder (ASD) is a group of neurological conditions, which hampers developmental of social interaction, communication and use of verbal and non-verbal language. The exact cause is still unknown. People with autism have issues in carrying out regular activities. Children with autism have issues during social interaction. Social interaction and communication are the core impairments of ASD, whereas, seizures, sensory issues, anxiety, sleep deficits, self-injury and others are associated symptoms. There is no definitive treatment for the treatment of core symptoms yet, however, the FDA have approved many drugs for associated symptoms. For instance, antipsychotics such as risperidone and aripripazole are used in treating irritability associated with disorder.

MARKET DYNAMICS

The autism spectrum disorders market is anticipated to grow in the forecast period owing to the increasing research and development for discovery of novel therapies. Growing pipeline for the autism spectrum disorder is one of the prime factors for the growth of the market. There is no current therapies for the treatment of autism spectrum disorders, which have increased number of untreated population. For instance, autism prevalence has increased by 15% in children, affecting 1 out of 59 children, the CDC. Moreover, increasing government efforts to increasing knowledge regarding autism is boosting the growth of the market. For instance, in August 2019, the Centers for Disease Control and Prevention announced to invest USD 27 million in the next five years to conduct the Study to Explore Early Development (SEED). This is one of the largest studies in the U.S., which will help in identifying risk factors in children for autism spectrum disorder (ASD).

MARKET SCOPE

The "Global Autism Spectrum Disorders Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of autism spectrum disorders market with detailed market segmentation by type, treatment type and geography. The global autism spectrum disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading autism spectrum disorders market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global autism spectrum disorders market is segmented on the basis of type, and treatment type. Based on type, the market is segmented as autistic disorder, pervasive developmental disorder, Asperger syndrome and others. Based on treatment type, the market is segmented as drug therapy and communication & behavioral therapy.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Autism Spectrum Disorders market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The autism spectrum disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting autism spectrum disorders market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the autism spectrum disorders market in these regions.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report covers key developments in the autism spectrum disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from autism spectrum disorders market are anticipated to lucrative growth opportunities in the future with the rising demand for autism spectrum disorders market in the global market. Below mentioned is the list of few companies engaged in the autism spectrum disorders market.

The report also includes the profiles of key autism spectrum disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  F. Hoffmann-La Roche AG
  •  Nobelpharma Co., Ltd.
  •  Johnson & Johnson
  •  Yamo Pharmaceuticals
  •  Curemark
  •  Servier
  •  Neurochlore

Pipeline Analysis

Many companies are engaged in the development of autism spectrum disorders drugs, which are currently in the pipeline. Some of the major brands are F. Hoffmann-La Roche AG, Nobelpharma Co., Ltd., Johnson & Johnson, Yamo Pharmaceuticals, Curemark, Servier, Neurochlore among others.
Some of the major pipeline drugs are mentioned below:
- In 2020, Roche's received breakthrough therapy designation for balovaptan in autism spectrum disorder from the FDA. Balovaptan is expected to be first pharmacotherapy, which will help in improving core social interaction and communication in patients
- In 2020, Yamo Pharmaceuticals, LLC, received Fast Track Designation for L1-79, which is a tyrosine hydroxylase inhibitor. This will help in reducing the socialization and communication symptoms in patients suffering with autism spectrum disorder (ASD)
- In May 2019, Finch Therapeutics received fast track designation by the FDA for its Full-Spectrum Microbiota, or FSM therapy for children with autism spectrum disorder
- In June 2019, Q BioMed Inc., which is commercial stage biotech company, filed for Orphan Drug designation for QBM-001. This product is being designed to treat pediatric minimally verbal autism (PVMA)

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. F. Hoffmann-La Roche AG
2. Nobelpharma Co., Ltd.
3. Johnson & Johnson
4. Yamo Pharmaceuticals
5. Curemark
6. Servier
7. Neurochlore

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Autism Spectrum Disorders Market